Loraz and Eloxatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Eloxatin (oxaliplatin). Common drug interactions include chest pain among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Eloxatin. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Eloxatin?

Eloxatin has active ingredients of oxaliplatin. eHealthMe is studying from 7,092 Eloxatin users. Check the latest studies of Eloxatin.

On Jul, 16, 2026

100 people who take Loraz and Eloxatin together, and have interactions are studied.

What are the common drug interactions of Loraz and Eloxatin, by gender? *:

female:

Chest pain
Febrile neutropenia (fever with reduced white blood cells)
Pain
Asthenia (weakness)
Diarrhoea
Dizziness
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Decreased appetite
Anaemia (lack of blood)
Constipation

male:

Nausea (feeling of having an urge to vomit)
Abdominal pain
Death
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Vomiting
Pneumonia
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Dry skin

What are the common drug interactions of Loraz and Eloxatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Vomiting
Abdominal pain
Constipation
Dehydration (dryness resulting from the removal of water)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Gastrointestinal obstruction
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nausea (feeling of having an urge to vomit)
Palpitations (feelings or sensations that your heart is pounding or racing)
Renal failure acute (rapid kidney dysfunction)

40-49:

Nausea (feeling of having an urge to vomit)
Back pain
Dehydration (dryness resulting from the removal of water)
Pyrexia (fever)
Flushing (the warm, red condition of human skin)
Abdominal distension
Abdominal pain
Abdominal pain lower
Asthenia (weakness)
Breath sounds

50-59:

Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Blood potassium decreased
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Dizziness
Dyspnoea (difficult or laboured respiration)
Heart rate increased
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Malignant neoplasm progression (cancer tumour came back)
Abdominal pain
Anaphylactic reaction (serious allergic reaction)

60+:

Nausea (feeling of having an urge to vomit)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Thrombocytopenia (decrease of platelets in blood)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Diarrhoea
Dry skin
Erythema (redness of the skin)
Gait disturbance

What are the existing conditions these people have? *

Colon Cancer: 18 people, 18.00%
Pancreatic Carcinoma (pancreatic cancer): 12 people, 12.00%
Metastases To Liver (cancer spreads to liver): 11 people, 11.00%
Gastric Cancer (stomach cancer): 5 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Eloxatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously